Muhammad Younus, MBBS, MS, Ph.D

Senior Director, Unit Lead Safety Surveillance Research
Pfizer Inc

Poster(s):

• (A-335) Leveraging Real-World Data for Regulatory Commitment: Methodological Considerations in a Post-Approval Safety Study Evaluating the Risk of Atrial Fibrillation (AF) Following Respiratory Syncytial Virus (RSV) Vaccination
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-093) Preliminary results from a European post authorization study to assess the safety of Paxlovid among patients with moderate or severe hepatic or renal impairment
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET